Equifax, Incorporated financials
$140.83−3.40%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 | FY20 Dec 31 | FY19 Dec 31 | FY18 Dec 31 | FY17 Dec 31 | FY16 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.07B | $5.68B | $5.27B | $5.12B | $4.92B | $4.13B | $3.51B | $3.41B | $3.36B | $3.14B |
| Gross profit | $3.43B | $3.16B | $2.93B | $2.94B | $2.94B | $2.39B | $1.99B | $1.97B | $2.15B | $2.03B |
| Gross margin | 56.4% | 55.7% | 55.7% | 57.5% | 59.8% | 57.9% | 56.6% | 57.8% | 64.0% | 64.6% |
| Operating income | $1.10B | $1.04B | $933.6M | $1.06B | $1.14B | $676.6M | -$335.4M | $448.0M | $831.7M | $825.1M |
| Net income | $660.3M | $604.1M | $545.3M | $696.2M | $744.2M | $520.1M | -$384.1M | $310.5M | $587.3M | $488.8M |
| Net margin | 10.9% | 10.6% | 10.4% | 13.6% | 15.1% | 12.6% | −11.0% | 9.1% | 17.5% | 15.5% |
| Diluted EPS | $5.32 | $4.84 | $4.40 | $5.65 | $6.02 | $4.24 | $-3.15 | $2.56 | $4.83 | $4.04 |
| EBITDA | $1.82B | $1.72B | $1.55B | $1.62B | $1.63B | $1.08B | $1.9M | $763.9M | $1.12B | $1.09B |
| Operating cash flow | $1.62B | $1.32B | $1.12B | $757.1M | $1.33B | $946.2M | $313.8M | $672.2M | $816.0M | $823.0M |
| Free cash flow | $1.13B | $813.0M | $515.5M | $132.6M | $865.8M | $524.9M | -$85.8M | $350.3M | $597.8M | $649.5M |
| Diluted shares | 124.1M | 124.9M | 123.9M | 123.3M | 123.6M | 122.8M | 122.0M | 121.4M | 121.5M | 121.1M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $180.8M | $169.9M | $216.8M | $285.2M | $224.7M | $1.68B |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $5.09B | $5.01B | $5.71B | $5.79B | $5.29B | $4.38B |
| Total assets | $11.86B | $11.76B | $12.28B | $11.55B | $11.04B | $9.61B |
| Total liabilities | $7.13B | $6.84B | $7.59B | $7.57B | $7.44B | $6.40B |
| Shareholders' equity | $4.62B | $4.81B | $4.55B | $3.97B | $3.60B | $3.21B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology